with fatal outcome. Clin Genet 2009; 76(5): 493-5 Chevillotte M, Landwehr S, Linta L, Frascaroli G, Lüske A, Buser C, Mertens T, von Einem J: Major tegument protein pp65 of human cytomegalovirus is required [...] Schlegelberger B, Kreipe H, Lehmann U: Comprehensive genetic and functional characterization of IPH-926: a novel CDH1-null tumour cell line from human lobular breast cancer. J Pathol 2009; 217(5): 620-32 [...] Kreipe H, Schlegelberger B: Histopathological criteria and selection algorithms for BRCA1 genetic testing. Cancer Genet Cytogenet 2009; 189(2): 105-11 Ganzenmueller T, Henke-Gendo C, Schlue J, Wedemeyer J,
Hartmann, Chair of Neuropathology, Institute of Pathology, MHH Brain tumor families and their genetic changes, Prof. Dr. med. Ruthild Weber, Institute of Human Genetics The CATNON study - Do we need to rethink [...] the exciting program: MRI for cranial tumors - a program for all entities? Dr. med. Peter Raab, Institute of Diagnostic and Interventional Neuroradiology, MHH Paraneoplastic neurological syndromes, Dr.
Pediatric Muscle Consultation, Cardiology, Orthopedics, Pneumology, Immunology and Rheumatology, Human Genetics, Physical Medicine and Rehabilitation, Siloah Clinic (Pneumology), Children's Hospital on the [...] ALS and muscle consultation Head: Prof. Dr. med. S. Petri The institute founded by the Society for Muscular Dystrophy (DGM) certified Neuromuscular Center of the MHH (Hannover Medical School) is an in [...] appears appropriate and is desired. In addition to clinical assessment, extensive laboratory tests, genetic tests and modern imaging and neurophysiological procedures in laboratories with many years of experience
updates ESMO treatment guidelines for biliary carcinoma Prof. Dr. Arndt Vogel has illustrated the genetic changes in bile duct cancer for which targeted therapies are already available. Photo: Maike Isfort [...] ducts and gallbladder. BCTs are rare and account for less than one percent of malignant neoplasms in humans. Overall, BCT has a poor prognosis. Five years after diagnosis, only 10 to 20 percent of those affected [...] n from the European Medicines Agency (EMA). Breakthrough in molecular sequencing The search for genetic changes using molecular sequencing has led to significant successes in the treatment of cancer in
detection and prevention of risks associated with genetic cell modification and training of young scientists are important missions of our Institute. The Institute of Experimental Hematology (IEH) contributes [...] Science at the IEH The Institute of Experimental Hematology (IEH) investigates the biology of blood cell formation and function with a special focus on genetic cell modification as a new therapeutic modality [...] assessment of novel therapeutic approaches. The experimental scope of our institute ranges from investigation of basic mechanisms of genetic cell modification to implementation of translational projects designed
/ Ms. Steinhage ENDOGEN Genetic disposition for endometrial cancer Study management: Molecular Gynecology Group of the Research Center ENDOMED Polymorphism, factors, genetic variability and predisposition [...] Inhibitors and Fulvestrant versus CDK4/6 Inhibitors and Fulvestrant in Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced, Unresectable or Metastatic Breast Cancer [...] first-line setting in patients with endocrine-sensitive PIK3CA-mutated hormone receptor-positive (HR), human epidermal growth factor receptor 2-negative (HER2), advanced breast cancer (ABC) Study conduct: Prof
in use act by interfering with the cell coat assembly. The parasites Leishmania , responsible for human diseases collectively called leishmaniases and the opportunistic fungus Aspergillus fumigatus , the [...] Our projects aim at: Identifying and characterizing new glycosylation pathways (ideally absent in human) Analyzing their importance for the pathogen survival, growth or virulence (in mice models) to identify [...] development of lead compounds (in collaboration with specialist). Methods commonly used include genetic manipulation of pathogens (e.g. gene disruption, conditional regulation of gene expression, protein
Neurology Institute of Biostatistics Institute of Clinical Pharmacology Department of Nuclear Medicine With external institutions - Germany-wide Section Biostatistics at Paul-Ehrlich-Institute Department [...] Unit, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig MPI Germany Massachusetts General Hospital, Harvard Medical School Harvard-MGH USA Rensselaer Polytechnic Institute RPI USA Tourette [...] and Psychotherapy, Albert-Ludwigs-University Freiburg With external institutions - International Cooperation partners in the TicGenetics study Rutgers University (Gary Heiman/Jay Tischfield). Children's
Transplantation Human Genetics Anesthesiology and Intensive Care Medicine Psycho-oncology Palliative medicine Comprehensive Cancer Center Hannover (Claudia von Schilling Center) Institute of Clinical Chemistry [...] Department of Radiotherapy and Special Oncology Clinical Department of Nuclear Medicine Institute of Radiology Institute of Pathology Cooperation partners within the MHH Cooperation partners within the MHH [...] to provide you with comprehensive treatment. Thanks to this close cooperation between different institutions, we can offer you as a patient a broad range of diagnostics and therapies that you will only find
case report ". https://pubmed.ncbi.nlm.nih.gov/40938529/ 03.09.2025 Today a project from MHH Human Genetics, MHH Pediatrics, HZI and MHH Nephropathology, among others, was published: "Presentation of patients [...] technology" with Histomography GmbH, Lung Pathology, Institute of Neuroanatomy and Cell Biology, LEBAO and Radiation Protection of the MHH with the Institute of X-ray Physics of the University of Göttingen [...] 2024 Today the paper "Heterozygous variants in the teashirt zinc finger homeobox 3 (TSHZ3) gene in human congenital anomalies of the kidney and urinary tract" was published. Nephropathology was a cooperation